To ensure that you always receive your Journal Watch Allergy / Asthma Alert, add the e-mail address
jw-allergy-mailer@alerts.stanford.edu to your address book.

Allergy / Asthma

Journal Watch
Go to Journal Watch Subscribe My Alerts
 

Allergy / Asthma for September 2, 2010

SUMMARY AND COMMENT

Hydroa Vacciniforme and Epstein-Barr Virus: An Unlikely Duo

August 20, 2010 | Craig A. Elmets, MD | Dermatology

Patients with HV had significantly higher levels of EBV DNA than 35 patients with other photosensitivity diseases.

Reviewing: Verneuil L et al. Br J Dermatol 2010 Jul 163:174

Free Full-Text Article

Summary and Comment

Hydroa Vacciniforme and Epstein-Barr Virus: An Unlikely Duo

Patients with HV had significantly higher levels of EBV DNA than 35 patients with other photosensitivity diseases.

Hydroa vacciniforme (HV) is a rare photosensitivity that manifests as papulovesicles and scarring following ultraviolet A (UVA) exposure. Although the pathogenesis of HV is unknown, an association with Epstein-Barr virus (EBV) has been suggested. Investigators performed a detailed study to assess the involvement of EBV in seven adults with HV.

UVA radiation was administered to the skin of three of these patients with active HV for up to 5 consecutive days and produced the characteristic umbilicated papulovesicles. Biopsy specimens taken from the photo-induced lesions were found to have significantly more EBV-positive cells than adjacent normal skin, an observation that was confirmed by polymerase chain reaction (PCR) analysis. On electron microscopy, viral particles were observed in keratinocytes from the lesional skin but not in surrounding normal skin. Blood samples showed greater amounts of EBV DNA in the patients with active disease than in those in remission, but the difference did not achieve statistical significance. However, the HV patients did have significantly greater levels of EBV DNA than the 35 control patients with other photosensitivity diseases (P<0.001); only 1 such control patient had elevated levels of EBV DNA.

Comment: Epstein-Barr virus has been previously reported in HV patients, particularly in those with severe disease, many of whom developed natural killer/T-cell Epstein-Barr virus–associated lymphoma. This thorough experimental design and highly sensitive techniques in this study found further support for involvement of EBV in the pathogenesis of this enigmatic disease. It will be interesting to see if this association extends to children, in whom most cases of HV occur. In addition to providing insight into HV pathogenesis, these findings may also have practical significance: At times, it can be difficult to differentiate HV from other photosensitive dermatoses; EBV serology could help differentiate HV from erythropoietic protoporphyria, polymorphous light eruption, and actinic prurigo.

Craig A. Elmets, MD

Published in Journal Watch Dermatology August 20, 2010

Citation(s):

Verneuil L et al. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: An assessment of seven adult patients with long-term follow-up. Br J Dermatol 2010 Jul; 163:174.

Medline abstract (Free)

Go to Journal Watch Subscribe My Alerts

SPECIAL OFFERS

Start Your 14-Day FREE Trial to Journal Watch Online.
Keeping up with the latest developments in medicine is central to your care of patients. But with all you do as a clinician, how do you find time to stay informed? You do what 350,000 physicians do: Stay informed with Journal Watch Online. Start your 14-Day FREE TRIAL today!

Thank you for signing up for this Journal Watch Alert.

We invite you to forward this e-mail to a friend.

To UNSUBSCRIBE from this or other Journal Watch Alerts, change delivery options or sign up for additional Journal Watch Alerts, go to My Alerts. If someone forwarded this Journal Watch Alert to you, register today for our free alert services.

Please do not reply to this e-mail. This is an automated mailbox. If you have any questions or comments, please e-mail us at jwatch@mms.org or contact our Customer Service department at (800) 843-6356.

Editorial, Business, and Subscription Offices:
860 Winter Street, Waltham, MA 02451-1413
Phone: (781) 893-3800 x5515 or (800) 843-6356

Editorial Policies | Privacy Policy | Terms and Conditions | Site Map

Home | About | Help | Contact | Register | Subscribe | Renew | My Alerts | My Account | CME

Copyright © 2010. Massachusetts Medical Society. All rights reserved.